Medios AG Asset Resilience Ratio
Medios AG asset resilience ratio. Medios AG (ILM1) has an Asset Resilience Ratio of 0.08% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ILM1 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Medios AG (2016–2025)
Asset resilience ratio of Medios AG from 2016 to 2025. This chart shows how Medios AG's Asset Resilience Ratio has changed over time. Read total liabilities of Medios AG for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Medios AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Medios AG (ILM1) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €748.00K | 0.08% |
| Total Liquid Assets | €748.00K | 0.08% |
Asset Resilience Insights
- Limited Liquidity: Medios AG maintains only 0.08% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Medios AG Industry Peers by Asset Resilience Ratio
Compare Medios AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.04% |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368 |
Medical Distribution | 1.77% |
|
ShareHope Medicine Co Ltd
TWO:8403 |
Medical Distribution | 3.61% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
Medios AG Asset Resilience Ratio by Year (2016–2025)
Medios AG asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Medios AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.10% | €883.00K ≈ $1.03 Million |
€903.04 Million ≈ $1.06 Billion |
+0.01pp |
| 2022-12-31 | 0.09% | €523.00K ≈ $611.44K |
€575.96 Million ≈ $673.36 Million |
-0.02pp |
| 2021-12-31 | 0.11% | €576.00K ≈ $673.40K |
€524.14 Million ≈ $612.78 Million |
-0.15pp |
| 2020-12-31 | 0.26% | €515.00K ≈ $602.09K |
€194.54 Million ≈ $227.43 Million |
+0.05pp |
| 2019-12-31 | 0.21% | €247.64K ≈ $289.52K |
€116.57 Million ≈ $136.28 Million |
-11.83pp |
| 2018-12-31 | 12.04% | €11.85 Million ≈ $13.85 Million |
€98.42 Million ≈ $115.06 Million |
-6.34pp |
| 2017-12-31 | 18.38% | €11.34 Million ≈ $13.26 Million |
€61.71 Million ≈ $72.14 Million |
-17.33pp |
| 2016-12-31 | 35.71% | €17.09 Million ≈ $19.98 Million |
€47.86 Million ≈ $55.95 Million |
-- |
About Medios AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and p… Read more